Comparison of Three Comorbidity Measures for Predicting In-Hospital Death through a Clinical Administrative Nacional

Iván Oterino-Moreira1, Susana Lorenzo-Martínez2, Ángel López-Delgado3

  • 1Department of Pharmacy, Hospital Universitario Fundación Alcorcón, 28922 Madrid, Spain.

Insights

The van Walraven comorbidity index (WCI) best predicts in-hospital mortality compared to the Charlson (CCI) and Elixhauser (ECI) indices. This study quantifies differences in prognostic capacity among these common comorbidity measures.

Area of Science:

  • Health Services Research
  • Clinical Epidemiology
  • Medical Informatics

Background:

  • Comorbidity indices are crucial for assessing patient prognosis and healthcare outcomes.
  • Existing literature validates various comorbidity scales, but their comparative prognostic capacity requires further investigation.
  • Understanding variations in predictive power among indices like Charlson (CCI), Elixhauser (ECI), and van Walraven (WCI) is essential for accurate mortality risk stratification.

Purpose of the Study:

  • To quantify prognostic differences between CCI, ECI, and WCI in predicting in-hospital mortality.
  • To identify the most effective comorbidity measurement index for predicting in-hospital mortality.

Main Methods:

  • Retrospective observational study analyzing 79,425 hospitalizations (2017-2021) using Minimum Basic Data Set (MBDS).
  • Calculation of CCI, ECI, and WCI using ICD-10 coding algorithms.
  • Evaluation of correlation (Spearman's rho) and concordance (Intraclass Correlation Coefficient - ICC) between indices.
  • Logistic regression and Receiver Operating Characteristic (ROC) curve analysis to compare predictive performance for in-hospital mortality.

Main Results:

  • The study included 79,425 admissions; in-hospital mortality rate was 4.47%.
  • Moderate correlations and fair-to-good concordance were observed between the three comorbidity indices (CCI, ECI, WCI).
  • All indices demonstrated that comorbidity increases in-hospital mortality risk, with the van Walraven comorbidity index (WCI) showing the highest predictive accuracy (AUC = 0.750).

Conclusions:

  • Comorbidity significantly impacts in-hospital mortality, with varying predictive strengths across different measurement scales.
  • The van Walraven comorbidity index (WCI) emerged as the superior predictor of in-hospital mortality among the evaluated indices.
  • Selection of an appropriate comorbidity index is critical for accurate prognostic assessment and clinical decision-making.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
256
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
232
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
219
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
117